Madrid, Spain

Carlos Sunkel

USPTO Granted Patents = 11 

 

Average Co-Inventor Count = 4.7

ph-index = 4

Forward Citations = 80(Granted Patents)


Location History:

  • Madrid 16, ES (1985)
  • Madrid, ES (1988 - 2005)
  • 28033, Madrid, ES (2006)

Company Filing History:


Years Active: 1985-2006

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Carlos Sunkel: Innovator in Pharmaceutical Compositions

Introduction

Carlos Sunkel is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of analgesic combinations. With a total of 11 patents to his name, Sunkel's work focuses on enhancing pain relief methods while minimizing side effects.

Latest Patents

Sunkel's latest patents include innovative pharmaceutical combinations that utilize N-acylated 4-Hydroxyphenylamine derivatives and caffeine. One of his inventions relates to the use of opioid and non-opioid analgesics combined with caffeine and specific derivatives to alleviate pain in mammals. These combinations are designed to exhibit enhanced analgesic potency without suppressing blood coagulation or causing significant hepatotoxic effects. Another patent also focuses on similar combinations, emphasizing the effectiveness of these analgesics in pain management.

Career Highlights

Throughout his career, Carlos Sunkel has worked with various companies, including Alter, S.A. His expertise in pharmaceutical innovations has positioned him as a key figure in the development of new pain relief methods. His contributions have been instrumental in advancing the field of analgesics.

Collaborations

Sunkel has collaborated with notable professionals in his field, including Julio Alvarez-Builla and Miguel Fau De Casa-Juana. These collaborations have further enriched his research and development efforts.

Conclusion

Carlos Sunkel's innovative work in pharmaceutical compositions has led to significant advancements in pain management. His patents reflect a commitment to improving the efficacy and safety of analgesic treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…